STOCK MARKET BSE NSE

COVID recovered with one/two doses of vaccine have higher protection against Delta variant: Study

Prior vaccination results in less severe disease against subsequent infection provide evidence that both humoral and cellular immune response play an important role in protection, as per the study.

Published: 03rd July 2021 11:53 PM  |   Last Updated: 03rd July 2021 11:53 PM   |  A+A-

A healthcare worker inoculates a dose of the COVID-19 vaccine to a beneficiary, in New Delhi on Saturday. (Photo | ANI)

A healthcare worker inoculates a dose of the COVID-19 vaccine to a beneficiary, in New Delhi on Saturday. (Photo | ANI)

By PTI

NEW DELHI: Breakthrough cases and COVID-19 recovered individuals with one or two doses of vaccine have relatively higher protection against Delta variant in comparison to those administered either one or two doses of Covishield, a study stated.

Prior vaccination results in less severe disease against subsequent infection provide evidence that both humoral and cellular immune response play an important role in protection, according to the study which is yet to be peer-reviewed and was posted on bioRxiv preprint server on Friday.

The study 'Neutralisation of Delta Variant with Sera of Covishield vaccines and COVID-19 Recovered Vaccinated Individuals' has been done by scientists from the Indian Council of Medical Research (ICMR), National Institute of Virology, Pune, and Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College, Pune.

ALSO READ | Covid jabs to key workers, then elderly followed by comorbid people of 24-60 yrs hikes impact: ICMR study

The recent emergence of B.1.617 lineage has created grave public health problem in India.

"The lineage further mutated to generate sub-lineages B.1.617.1 (Kappa), B.1.617.2 (Delta) and B.1.617.3. Apparently, the Delta variant has slowly dominated the other variants. With this, the World Health Organisation has described this sub-lineage as variant of concern," the study stated.

"The high transmissibility associated with Delta variant led to second wave of the pandemic in India which affected millions of people.

Besides this, variant of concerns have been reported to show lower neutralisation to several approved vaccines.

This has led to breakthrough infections after completion of vaccination regimen," it said.

There is limited information available on the duration of protective immune response post-infection, vaccination or breakthrough infection with SARS-CoV-2.

The study evaluated immune response in sera of the Covishield vaccinated individuals belonging to categories-- one dose vaccinated, two doses vaccinated, COVID-19 recovered plus one dose vaccinated, COVID-19 recovered plus two doses vaccinated and breakthrough COVID-19 cases.

"The findings of the study demonstrated that the breakthrough cases and COVID-19 recovered individuals with one or two dose of vaccine had relatively higher protection against Delta variant in comparison to the participants who were administered either one or two doses of Covishield.

"Prior vaccination results in less severe disease against subsequent infection provide evidence that both humoral and cellular immune response play an important role in protection," the study added.

ALSO WATCH:



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp